Paul Hanavan

Paul Hanavan, PhD has a diverse work experience in the field of scientific research. Paul is currently working as a Principal Scientist at Odyssey Therapeutics since November 2021. Prior to this role, they were a Scientist III at Zymergen from May 2021 to November 2021. Before that, they served as a Senior Scientist at Lodo Therapeutics Corporation from November 2019 to May 2021. Paul also worked at RenBio as a Research Scientist II from January 2019 to October 2019, and as a Research Scientist from June 2016 to January 2019. Paul began their career as a Graduate Student at Arizona State University from August 2010 to December 2015. During their time at the university, they also worked as a Research Technician from December 2008 to August 2010, and as a Student Researcher from January 2007 to December 2008. Paul gained initial research experience as a Student Research Volunteer at Boston University School of Medicine from August 2004 to August 2005.

Paul Hanavan, PhD obtained their Doctor of Philosophy (Ph.D.) in Molecular and Cellular Biology from Arizona State University in 2015. Prior to that, they obtained their Bachelor of Science (B.S.) in Biology from the same institution in 2008.